Oral lesions in dermatitis herpetiformis. 1973

N G Fraser, and N W Kerr, and D Donald

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009061 Mouth Mucosa Lining of the ORAL CAVITY, including mucosa on the GUMS; the PALATE; the LIP; the CHEEK; floor of the mouth; and other structures. The mucosa is generally a nonkeratinized stratified squamous EPITHELIUM covering muscle, bone, or glands but can show varying degree of keratinization at specific locations. Buccal Mucosa,Oral Mucosa,Mucosa, Mouth,Mucosa, Oral
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D009912 Oral Manifestations Disorders of the mouth attendant upon non-oral disease or injury. Manifestation, Oral,Manifestations, Oral,Oral Manifestation
D011693 Purpura Purplish or brownish red discoloration, easily visible through the epidermis, caused by hemorrhage into the tissues. When the size of the discolorization is >2-3 cm it is generally called Ecchymoses (ECCHYMOSIS). Petechiae,Purpuras
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D001768 Blister Visible accumulations of fluid within or beneath the epidermis. Bulla,Vesication,Bleb,Bullae,Bullous Lesion,Blebs,Blisters,Bullous Lesions,Lesion, Bullous,Lesions, Bullous,Vesications
D003622 Dapsone A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8) Diaminodiphenylsulfone,Sulfonyldianiline,4,4'-Diaminophenyl Sulfone,Avlosulfone,DADPS,Dapsoderm-X,Dapson-Fatol,Diaphenylsulfone,Disulone,Sulfona,4,4' Diaminophenyl Sulfone,Sulfone, 4,4'-Diaminophenyl

Related Publications

N G Fraser, and N W Kerr, and D Donald
July 1986, Oral surgery, oral medicine, and oral pathology,
N G Fraser, and N W Kerr, and D Donald
January 1972, Therapeutische Umschau. Revue therapeutique,
N G Fraser, and N W Kerr, and D Donald
January 1971, Oral surgery, oral medicine, and oral pathology,
N G Fraser, and N W Kerr, and D Donald
January 2012, Clinical & developmental immunology,
N G Fraser, and N W Kerr, and D Donald
June 1946, Archives of dermatology and syphilology,
N G Fraser, and N W Kerr, and D Donald
January 1987, La Ricerca in clinica e in laboratorio,
N G Fraser, and N W Kerr, and D Donald
January 2023, International journal of environmental research and public health,
N G Fraser, and N W Kerr, and D Donald
January 1968, Archives belges de dermatologie et de syphiligraphie,
N G Fraser, and N W Kerr, and D Donald
November 2003, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
N G Fraser, and N W Kerr, and D Donald
January 1952, Indian journal of pediatrics,
Copied contents to your clipboard!